The Synergy Between Radiotherapy and Molecularly Targeted Agents

$1,349,207ZIAFY2010CANIH

Division Of Clinical Sciences - Nci

Investigators

Linked publications & trials

Paper 38811596 Paper 38612892 Paper 38544831 Paper 34158343 Paper 33939204 Paper 33672628 Paper 32960814 Paper 32211051 Paper 32000167 Paper 31836083 Paper 31618122 Paper 31266294 Paper 29866745 Paper 29549168 Paper 29488099 Paper 29294092 Paper 29199006 Paper 27885363 Paper 26194676 Paper 25991676 Paper 25939762 Paper 25722303 Paper 23790466 Paper 22431923 Paper 22415465 Paper 22397984 Paper 22369205 Paper 22356893 Paper 22207914 Paper 22207913 Paper 22103617 Paper 21690569 Paper 21647871 Paper 21632852 Paper 21595825 Paper 21472002 Paper 21322555 Paper 20629992 Paper 20477491 Paper 20387308 Paper 20361469 Paper 19823740 Paper 19789319 Paper 19703306 Paper 19671863 Paper 19509253 Paper 19464627 Paper 19372578 Paper 19366835 Paper 19338375 Paper 19147766 Paper 18765532 Paper 18594006 Paper 18483266 Paper 18256832 Paper 18245557 Paper 18236716 Paper 17671112 Paper 17569618 Paper 16914588 Paper 16796796 Paper 16782459 Paper 16675588 Paper 16636135 Paper 16424041 Paper 16377411 Paper 16061682 Paper 15958643 Paper 15958639 Paper 15928080 Paper 15867235 Paper 15578701 Paper 14752073

Abstract

The goal of this project is to study the interaction of radiotherapy and molecularly targeted agents. This project focuses on expanding drugs that show synergy in vitro to the in vivo setting, with the goal of translation to the clinic. This is a translational project. We begin in the laboratory testing drugs in combination with radiotherapy in vitro. Once in vitro sensitivity is comfirmed then we do in vivo work with sc or ic animal models. If a drug is shown to sensitize tumor cells to radiation then we bring it to the clinic.

View original record on NIH RePORTER →